medigraphic.com
ISSN 1405-8790 (Print)

2004, Number 2

<< Back Next >>

Rev Mex Med Fis Rehab 2004; 16 (2)

Botulin toxin: Its use in rehabilitation medicine, myths and realities

Juárez SG

Language: Spanish
References: 27
Page: 37-40
PDF size: 56.75 Kb.


ABSTRACT

With the presence of the botulinum toxin inside the rehabilitation field has been created a controversy regarding its use as well as the therapy results in many pathologies of muscular and neurological nature. Due to this matter the main object of this article is to review its main directions among others the spastic syndrome treatment and some others concepts of its constitutes myths and its reality according to therapy concepts.


REFERENCES

  1. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991; 324: 1186-94.

  2. Bikhazadi NB, Mass CS. Refinement in the rehabilitation of the paralyzed face using botulinum toxin. Otolaryngol Head Neck Surg 1997; 117(4): 303-7.

  3. Clark RP, Berris CE. Botulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis. Plast Reconstr Surg 1989; 84: 353-5.

  4. Andrés DJ. Dolor musculoesquelético: tratamiento intramuscular con toxina botulínica. Dolor 2000; 15(1): 25-28.

  5. Alo K, Yland MJ, Kramer DL et al. Botulinum Toxin in the treatment of myofascial pain. Pain Clinic 1997; 10(10): 107-16.

  6. Comella CL. Electromiography-assisted botulinum toxin injections for cervical distonia. In: Therapy with botulinum toxin. Jankovic J, Hallett M (eds) New York: Marcel Dekker, Inc 1994: 289-98.

  7. Chershire WP, Abashjan 5W, Mann JO. Botulinum toxin in the treatment of myofascial pain syndrome. Pain 1994; 59: 65-9.

  8. Acquadro MA, Borodic GE. Treatment of myofascial pain with botulinum A toxin. Anesthesiology 1994; 80: 705-6.

  9. Scott AB, Kennedy RA, Stubbs MA. Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol 1985; 103: 347-50.

  10. Carruthers J, Carruthers A. The adjunctive usage of botulinum toxin. Dermatol Surg 1998; 24: 1244-7.

  11. Matarasso SL. Complications of botulinum A exotoxin for hyperfunctional lines. Dermatol Surg 1998; 24: 1249-54.

  12. Tsui JKC. Botulinum toxin as a therapeutic agent. Pharmacol Ther 1996; 72: 13-24.

  13. Jankovic J, Hallen M (eds). Therapy with Botulinum Toxin. New York: Marcel Dekker, Inc 1994.

  14. Tschopp KP, Cysin C. Local injection therapy in 107 patients with myofascial pain syndrome of the head and neck. ORL J Otorhinolaryngol ReLat Spec 1996; 58: 306-10.

  15. Wreje U, Brorsson B. A multicenter randomized controlled trial of injections of sterile water and salme for chronic myofascial pain syndromes. Pain 1995; 65: 441-4.

  16. Shaari CM, Sanders L. Assessment of the biological activity of botulinum toxin. In: Therapy with Botulinum Toxin. Jankovic J, Hallett M (eds.). New York: Marcel Dekker, Inc 1994: 159-70.

  17. Stell R, Thompson PD, Marsden CD. Botulinum toxin in spasmodic torticollis. J Neurosurg Psychiatry 1998; 51: 920-3.

  18. Patrinely JR, Whiting AS, Anderson RL. Local side effects of botulinum toxin injections. In: Advances in Neurology, Facial Dyskinesias. Vol. 49. New York: Rayen Press 1988: 439-99.

  19. Klein AW, Manteli A. Electromyographic guidance to injecting botulinum toxin. Dermatol Surg 1998; 24: 184-6.

  20. Hesse S, Reiter F, Konrad M et al. Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spacity after stroke: a randomized, double blind, placebo-controlled trial. Clin Rehabil 1996; 12: 361-8.

  21. Hatheway CL, Dnag C. Immunogenicity of the neurotoxins of Clostridium botulinum. In: Therapy with Botulinum Toxin. Jankovic J, Hallett M (eds.). New York: Marcel Dekker, Inc 1994: 93-107.

  22. Siatkowski RM, Tyutyunikow A, Bligan AW. Serum antibody production to botulinum A toxin. Ophthalmology 1993; 1: 1861-6.

  23. Jankovic J, Schwartz K. Response and immunoresistance to botulinum toxin injections. Neurology 1995; 45: 1743-6.

  24. Simpson LL. The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol Rev 19981; 33: 155-118.

  25. Watanabe Y, Bakheit AM, Mc Llellan DL. A study of the effectiveness of botulinum toxin type A in the management of muscle spasticy. Disabil Rehabil 1998; 20: 62-65.

  26. López del Val LJ, Castro GA. Toxina botulínica aplicaciones terapéuticas. Editorial Masson, Barcelona, España.

  27. Archivo Clínico de la Unidad de Medicina Física y Rehabilitación Centro “Hospital Colonia” IMSS México, DF.




2020     |     www.medigraphic.com